Fenretinide can indirectly modulate antioxidant Nrf2 activity increasing β-carotene accumulation [96], which was shown to prevent neuronal loss in ROS-associated brain diseases also by Nrf2 increase [97,98]. The gene discussed is NFE2L2; the disease is brain disorder.